Walder Wyss advised Evulpo, a Swiss EdTech start-up, throughout completion of a CHF 8.8 million Series A financing round. The investors The round saw participation from new and existing investors, including Serpentine Ventures, as well as several Swiss family offices and individuals such as president of the board of HIAG Felix Grisard, SwissLife’s ex-CEO Bruno […]
Kellerhals Carrard advised Comphya, a medtech spin-off from EPFL Lausanne, throughout closing the second tranche of a CHF 7.5 million Series A financing round. The context Comphya will destine the proceeds toward growing the project of
Kellerhals Carrard advised RTDT Laboratories on its financing round. An ETH Zurich spin-off, RTDT Laboratories developed Aerosense – a wireless, ultra-thin sensor patch coupled with AI-driven analytics, providing high-frequency aerodynamic and structural insights directly from wind
Kellerhals Carrard advised Grensol throughout its CHF 1.8 million seed equity round. The proceeds will support the construction and scale-up the compay’s first operational site in Biberist, in the Canton of Solothurn, Switzerland. Buildify Earth,
Walder Wyss advised askEarth, a Zurich-based deep-tech startup specialised in geospatial AI, in connection with the closing of its seed financing round. A spin-off from UZH, ETH and EPFL, the Swiss company raised an amount
Wenger Vieli advised Swiss AI company Modulos on all Swiss legal and tax matters concerning its CHF 8.7 million pre-Series A financing round. The context The proceeds from the financing round will be directed toward scaling-up
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Kellerhals Carrard advised Positrigo throughout its latest financing round. Raising an amount of CHF 7 million, the round in question was led by HealthCap, with participation from Navivo Capital as well as several family offices
Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
